申请人:Development Center for Biotechnology
公开号:US05840991A1
公开(公告)日:1998-11-24
The invention relates to novel compounds of formula (I) ##STR1## wherein R.sub.1 represents hydrogen, hydroxy or alkoxy; R.sub.2, R.sub.3, R.sub.4 and R.sub.5 may be hydrogen or alkyl; and n is 0,1 or 2; and the pharmaceutically acceptable salts thereof. The invention also relates to the processes for preparing the compounds of formula (I), and the pharmaceutical compositions containing them, and their use as a low density lipoprotein peroxidation inhibitors, anti-atherosclerotic agents and/or antihyperlipidemic agents.
本发明涉及式(I)的新化合物:##STR1##其中R.sub.1代表氢,羟基或烷氧基;R.sub.2,R.sub.3,R.sub.4和R.sub.5可以是氢或烷基;n为0、1或2;以及其药学上可接受的盐。本发明还涉及制备式(I)化合物的方法,以及包含它们的制药组合物,以及它们作为低密度脂蛋白过氧化物酶抑制剂、抗动脉粥样硬化剂和/或降血脂剂的用途。